RNA-sequencing revealed high expression of FATP1 in BM CD8+ T cells from MM patients, and FATP1 blockade rescued CD8+ T-cell function, thus representing a novel target for anti-MM immunotherapy. The gene discussed is CD8A; the disease is Miyoshi myopathy.